EN
|
ES
|
DE
|
FR
|
IT
|
日本語
|
한국어
|
中文
Home
About
The Firm
Our People
Practices
Overview
Patent Prosecution
Patent Office Litigation
Patent Portfolio Strategy & Management
Technologies
Biotechnology
Chemical & Nano Technologies
Manufacturing
Medical Devices
Pharmaceuticals
Power & Renewable Technology
Software & Computer Technologies
News & Events
Contact
biotech
Filter by
Categories
Tags
Authors
Show all
All
News / Events
Patent Prosecution
Uncategorized
All
2018 ASC Meeting
acquired
acquisition
Alumni
American Chemical Society
Animal Ventures
appeal
attorney
biotech
Blockchain
Blockchain startups
Boston
broad institute
business strategy
Caldwell Intellectual Property Law
Caldwell IP
Cambridge
Cambridge Patent Law
cas9
Christian Wentz
Chung Dae-Sun
Commercial
crispr
Emily Gaukstern
Event
FIFA
gene editing
George Washington University
Hack
HDAC
Hyundai
ICO Alert
Internet Of Things
IoT
IOTA
Katherine Ann Rubino
Keegan M. Caldwell
Keegan M. Caldwell PhD
Kevin Chesters
lawyer
lawyers
life sciences
Lindsey Powell
Maggie Teliska-Parke
medtech
Micah Drayton
Milton Oliver
MIT
MIT Enterprise Forum
MIT Enterprise Forum of Cambridge
Networking
Networking Event
open source
patent
Patent Attorney
Patent Portfolio Strategy & Management
Patents
ProtoLabs
ptab
RAPID
Red Sox; Fenway Park; Solar; energy; MLB; LED retrofits; World Series; 2018;
RENOUN
software
startup
startup patents
startups
Tangle Technology
The Barking Crab
Tom Serres
Umass Boston
university of california
vc
venture capital
Westworld
Whitepaper
World Cup 2018
Zug
All
admin
Performance Foundry
Emily Gaukstern
Katie Rubino
Keegan Caldwell, PhD
Lindsey Powell
Micah Drayton
website_admin
October 31, 2018
Differences Betweeen Medtech and Blockchain IP Strategies (VIDEO)
According to IP experts, outside of technical limitations of blockchain technology, the greatest challenge to becoming mainstream is a lack of trust (no pun intended) that prevents many companies from adopting blockchain into their structure.